Molecular Diagnostics

Simple Blood Test Could Improve Treatment for Neuroblastoma
A simple blood test could identify which children are unlikely to respond to treatment for a particularly aggressive form of neuroblastoma, which is the most common extracranial solid cancer in childhood and the most common cancer in infancy. More...28 May 2014




In Other News
Duplicated Gene Found for Highly Prevalent Facial Anomaly
Noninvasive Analysis of Mother's Blood Detects Fetal Chromosomal Abnormalities
Exome Sequencing Will Help Diagnose Patients with Unknown Disorders
Specific Tissues and Organs May Be Monitored by Whole Blood Transcriptome Analysis
New Functionalities Introduced for Microbial High-Throughput MALDI-TOF MS Platform
Host RNA Expression Diagnoses Childhood Tuberculosis
Microfluidic Technology Reveals Early Pancreatic Cancer Biomarker
Genetic Mutations Identified in Human Blood Diseases
Gene Predicts Prognosis of Breast Cancer Patients Treatment Response
Lab to Specialize in Biomarker Diagnostics for Gynecologic Cancers
HPV Test Approved for Primary Screening of Cervical Cancer
Hybridization-Based Solid Tumor Panel Delivers Consistent, Reliable Results
Cheaper Gene Panels Are Useful Alternative to Whole-Genome Sequencing
Genome Sequencing of MRSA Infection Predicts Disease Severity
New Test Could Accurately Predict Prostate Cancer Recurrence
Molecular-Based Techniques Diagnose Leprosy
Blood Test Provides Rapid Method of Detecting Solid Cancers
Blood Tests Predict Risk of Sudden Cardiac Death
Testing for Atypical Hemolytic Uremic Syndrome Goes NexGen
Imaging and Blood Test Work Together to Optimize Evaluation of Ovarian Cancer Risk
American Diagnostic Laboratory Offers Genetic Test for Calreticlin Gene Mutations
Microarray Gene Expression Approach May Help Predict Cancer Patient Survival
A Specific Mutation Links Some Forms of Inherited Melanoma
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.